These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7620712)

  • 1. A novel enhancing effect of clofilium on transient outward-type cloned cardiac K+ channel currents.
    Kobayashi T; Mikala G; Yatani A
    Br J Pharmacol; 1995 Mar; 114(6):1222-6. PubMed ID: 7620712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Block of gating currents related to K+ channels as a mechanism of action of clofilium and d-sotalol in isolated guinea-pig ventricular heart cells.
    Malécot CO; Argibay JA
    Br J Pharmacol; 1999 Sep; 128(2):301-12. PubMed ID: 10510439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of potassium currents in rat ventricle by clofilium and its tertiary homolog.
    Castle NA
    J Pharmacol Exp Ther; 1991 Apr; 257(1):342-50. PubMed ID: 2019997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Block of the inactivating potassium channel by clofilium and hydroxylamine depends on the sequence of the pore region.
    Yool AJ
    Mol Pharmacol; 1994 Nov; 46(5):970-6. PubMed ID: 7969088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of clofilium block of the human Kv1.5 delayed rectifier potassium channel.
    Malayev AA; Nelson DJ; Philipson LH
    Mol Pharmacol; 1995 Jan; 47(1):198-205. PubMed ID: 7838129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LY 97241 accelerates the apparent rate of inactivation of transient outward K+ current: characterization of open channel block.
    Zhang ZH; Steinberg MI
    J Pharmacol Exp Ther; 1995 Jul; 274(1):249-57. PubMed ID: 7616405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic drugs, clofilium and cibenzoline are potent inhibitors of glibenclamide-sensitive K+ currents in Xenopus oocytes.
    Sakuta H; Okamoto K; Watanabe Y
    Br J Pharmacol; 1993 Jul; 109(3):866-72. PubMed ID: 8358576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Block of heart potassium channels by clofilium and its tertiary analogs: relationship between drug structure and type of channel blocked.
    Arena JP; Kass RS
    Mol Pharmacol; 1988 Jul; 34(1):60-6. PubMed ID: 2455861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct mechanisms of block of Kv1.5 channels by tertiary and quaternary amine clofilium compounds.
    Steidl JV; Yool AJ
    Biophys J; 2001 Nov; 81(5):2606-13. PubMed ID: 11606274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of potassium channel blockers on the action potentials and contractility of the rat right ventricle.
    Doggrell SA; Bishop BE
    Gen Pharmacol; 1996 Mar; 27(2):379-85. PubMed ID: 8919661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of delayed rectifier K+ currents in neuroblastoma x glioma hybrid (NG 108-15) cells by clofilium, a class III antidysrhythmic agent.
    Reeve HL; Peers C
    Br J Pharmacol; 1992 Feb; 105(2):458-62. PubMed ID: 1559135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clofilium-induced block of delayed rectifier type K+ current in atrial tumor cells (AT-1 cells).
    Bhattacharyya ML; Sarker S; Mull KP; Debnam Q
    J Mol Cell Cardiol; 1997 Jan; 29(1):301-7. PubMed ID: 9040045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity of class-III antiarrhythmic action of clofilium in guinea pig ventricular myocytes.
    Li Q; Himmel HM; Ravens U
    J Cardiovasc Pharmacol; 1996 Mar; 27(3):401-10. PubMed ID: 8907802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Block of transient outward-type cloned cardiac K+ channel currents by quinidine.
    Yatani A; Wakamori M; Mikala G; Bahinski A
    Circ Res; 1993 Aug; 73(2):351-9. PubMed ID: 8330377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo targeting of ERG potassium channels in mice and dogs by a positron-emitting analogue of fluoroclofilium.
    Kim SW; Yang SD; Ahn BJ; Park JH; Lee DS; Gessner G; Heinemann SH; Herdering W; Yu KH
    Exp Mol Med; 2005 Aug; 37(4):269-75. PubMed ID: 16155403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hEAG1 and hERG1 potassium channels by clofilium and its tertiary analogue LY97241.
    Gessner G; Heinemann SH
    Br J Pharmacol; 2003 Jan; 138(1):161-71. PubMed ID: 12522086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural determinants of HERG channel block by clofilium and ibutilide.
    Perry M; de Groot MJ; Helliwell R; Leishman D; Tristani-Firouzi M; Sanguinetti MC; Mitcheson J
    Mol Pharmacol; 2004 Aug; 66(2):240-9. PubMed ID: 15266014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacological properties of K+ currents from rabbit isolated aortic smooth muscle cells.
    Halliday FC; Aaronson PI; Evans AM; Gurney AM
    Br J Pharmacol; 1995 Dec; 116(8):3139-48. PubMed ID: 8719788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic and bradycardic drugs inhibit currents of cloned K+ channels, KV1.2 and KV1.4.
    Yamagishi T; Ishii K; Taira N
    Eur J Pharmacol; 1995 Aug; 281(2):151-9. PubMed ID: 7589202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-activated potassium channels in native endothelial cells from rabbit aorta: conductance, Ca2+ sensitivity and block.
    Rusko J; Tanzi F; van Breemen C; Adams DJ
    J Physiol; 1992 Sep; 455():601-21. PubMed ID: 1484364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.